| Pharmaceutical Information |
| Drug Name |
Ceftaroline fosamil |
| Drug ID |
BADD_D00398 |
| Description |
Ceftaroline fosamil is a cephalosporin antibacterial indicated for the treatment of the following infections caused by designated susceptible bacteria:
Acute bacterial skin and skin structure infections.
Community-acquired bacterial pneumonia. |
| Indications and Usage |
Ceftaroline fosamil is indicated for the treatment of patients with the following infections caused by susceptible isolates of the designated microorganisms. |
| Marketing Status |
approved; investigational |
| ATC Code |
J01DI02 |
| DrugBank ID |
DB06590
|
| KEGG ID |
D08884
|
| MeSH ID |
C515501
|
| PubChem ID |
9852981
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
0456-0400; 0456-0600 |
| UNII |
7P6FQA5D21
|
| Synonyms |
ceftaroline fosamil | Teflaro | TAK-599 | TAK599 | PPI-0903 | PPI0903 |
|
| Chemical Information |
| Molecular Formula |
C22H21N8O8PS4 |
| CAS Registry Number |
229016-73-3 |
| SMILES |
CCON=C(C1=NSC(=N1)NP(=O)(O)O)C(=O)NC2C3N(C2=O)C(=C(CS3)SC4=NC(=CS4)C5=CC=[N+](C=
C5)C)C(=O)[O-] |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
